Raz Guy, Safir Oleg A, Backstein David J, Lee Paul T H, Gross Allan E
28 Truscott Street, North Ryde, NSW 2113, Australia. E-mail address:
Mount Sinai Hospital, 600 University Avenue, Suite 476A, Toronto, ON M5G 1X5, Canada. E-mail address for O.A. Safir:
J Bone Joint Surg Am. 2014 Jul 2;96(13):1101-1107. doi: 10.2106/JBJS.M.00769.
Osteochondral defects of the knee in young, active patients represent a challenge to the orthopaedic surgeon. Our study examined long-term outcomes of the use of fresh allograft for posttraumatic osteochondral and osteochondritis dissecans defects in the distal aspect of the femur.
We reviewed the cases of sixty-three patients who underwent osteochondral allograft transplantation to the distal aspect of the femur between 1972 and 1995. Five patients who resided out of the country were lost to follow-up. Indications for the allograft procedure were an age of less than fifty years and a unipolar posttraumatic osteochondral or osteochondritis dissecans defect in the distal aspect of the femur that was larger than 3 cm in diameter and 1 cm in depth.
Fifty-eight patients ages eleven to forty-eight years at the time of surgery (mean age, twenty-eight years) were followed for a mean of 21.8 years (range, fifteen to thirty-two years). Thirteen of the fifty-eight cases required further surgery; three underwent graft removal, nine were converted to total knee arthroplasty, and one underwent multiple debridements followed by above-the-knee amputation. Three patients died during the study due to unrelated causes. A Kaplan-Meier analysis of graft survival showed rates of 91%, 84%, 69%, and 59% at ten, fifteen, twenty, and twenty-five years, respectively. Patients with surviving grafts had good function, with a mean modified Hospital for Special Surgery (HSS) score of 86 at fifteen years or more following the allograft transplant surgery. Late osteoarthritic degeneration on radiographs was associated with lower HSS scores and poorer clinical outcomes.
Fresh osteochondral allograft was found to provide a long-term solution for large articular cartilage defects in the distal aspect of the femur in young, active patients.
Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence.
对于年轻、活跃的患者,膝关节的骨软骨缺损给骨科医生带来了挑战。我们的研究探讨了使用新鲜同种异体移植物治疗股骨远端创伤后骨软骨缺损和剥脱性骨软骨炎的长期疗效。
我们回顾了1972年至1995年间接受股骨远端骨软骨异体移植的63例患者的病例。5名居住在国外的患者失访。同种异体移植手术的指征为年龄小于50岁,股骨远端单极创伤后骨软骨或剥脱性骨软骨炎缺损,直径大于3 cm,深度大于1 cm。
58例患者手术时年龄为11至48岁(平均年龄28岁),平均随访21.8年(范围15至32年)。58例中有13例需要进一步手术;3例行移植物取出术,9例行全膝关节置换术,1例行多次清创术,随后行膝上截肢术。3例患者在研究期间因无关原因死亡。对移植物存活情况进行的Kaplan-Meier分析显示,10年、15年、20年和25年的存活率分别为91%、84%、69%和59%。移植物存活的患者功能良好,同种异体移植手术后15年或更长时间的平均改良特种外科医院(HSS)评分为86分。X线片上的晚期骨关节炎退变与较低的HSS评分和较差的临床结果相关。
新鲜骨软骨同种异体移植为年轻、活跃患者股骨远端的大关节软骨缺损提供了一种长期解决方案。
治疗性IV级。有关证据水平的完整描述,请参阅作者指南。